Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
This colorectal tumor-on-chip model is an original and reliable platform for high-throughput drug screening and genetic expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Design and characterization of the microfluidic chip. (A) Profilometer characterization: 3D map of the microfluidic chip. Representative image of quality control and characterization of the microfluidic chip features. The central chamber is 5 mm in diameter and 126 μm in depth, with a separate inlet and outlet for hydrogel injection. The two lateral channels, each 100 μm in width and 126 μm in depth, are not interconnected, opening up the possibility of perfusing two distinct solutions. (B) Schematic of chip design and zoom-in image of the concept of colorectal tumor-on-a-chip model: Round microfluidic central chamber in which HCT-116 cancer cells are embedded in Matrigel; HCoMECs are seeded in the side channels to form a 3D vessel-like assembly. (C) Establishment of a microvascular 3D microenvironment of colorectal tumor-on-a-chip: HCT-116 CRC cells embedded in Matrigel (in central chamber, stained in red) and HCoMECs (in lateral microchannels, stained in yellow) at day 1 (1D) and day 5 (5D) of culture. Endothelial cells start to invade the central chamber filled with Matrigel in response to VEGF presence. (D) Fluorescence microscopy image of microfluidic lateral channel mimicking prevascularization with HCoMECs after 5 days of culture [4′,6-diamidino-2-phenylindole (DAPI) blue, nuclei; phalloidin green, F-actin filaments]. Representative fluorescence microscopy close-up image of microchannel cross section showing endothelial cells aligning and creating an endothelialized lumen within the microchannel.](https://figures.cochat.ai/paper-figures/e6920bdb0956445d8d19309ea14d3e31/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-1.jpg)

![Fig. 3 Schematic representation of fluorescent nanoparticle gradient formation. (A) Transmission electron microscopy image of individual CMCht/PAMAM dendrimer nanoparticle, representative image of chip connected to tubing perfusing the nanoparticle solution, and zoom-in confocal microscopy image confirming FITC-labeled CMCht/PAMAM dendrimer nanoparticles’ dispersion in Matrigel. (B) Panel of fluorescence microscopy images of FITC-labeled nanoparticle gradient up to 12 hours. (C) Quantification of fluorescence: Intensity [in arbitrary units (a.u.)] versus distance (in micrometers) across the chip up to 12 hours [measurements according to the direction of the green arrow indicated in (B)]. (D) 3D projection of FITC-labeled nanoparticle gradient according to fluorescence intensity.](https://figures.cochat.ai/paper-figures/708a4d00001f4aab95398541a1dadede/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-3.jpg)
![Fig. 4 GEM drug effect on colorectal tumor model. (A) Release profile of GEM: Cumulative release (in hours) of GEM at pH 7.4 in phosphate-buffered saline (PBS), at 37°C and stirred at 60 rpm, determined by ultraviolet (UV) spectrophotometer set to 275 nm. The results are expressed as means ± SD (n = 6). (B) Schematic representation of experimental setup [perfusion of culture medium through one inlet and one outlet and of culture medium supplemented with GEM-loaded dendrimer nanoparticles (0.5 mg/ml) through the other inlet and outlet]; the areas defined for cell death quantification are delimited by dashed lines, and each ring is assigned D1 to D3 and M1 to M3. (C) Representative images of fluorescence microscopy images of live/dead assay performed on microfluidic chip at days 1 and 5. (D) Quantification of cell death, represented as percentage, based on the microscopy data. Data are presented as means ± SD (n = 3). The asterisk (*) denotes statistical differences (P < 0.05). Scale bars, 1000 μm. NP, nanoparticle; CTRL, control.](https://figures.cochat.ai/paper-figures/27813f8b3257452bb0dbcf8a091e4f62/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-4.jpg)
![Fig. 5 Gene expression analysis and immunocytochemistry on a chip. (A) Representation of hydrogel retrieval containing HCT-116 cells from the chip for gene expression analysis. (B) Gene expression of Ki-67, Casp-3, and MMP-1, in the absence (control) and presence of GEM, at days 1 and 5. The values for controls are represented by the dashed line. The asterisk (*) indicates significant differences when comparing the same condition at two different time points. The hash key (#) indicates significant differences when comparing to controls at the same time point. Data represent mean values of three independent experiments ± SD. RPS27A, ribosomal protein S27A. (C) Immunohistochemistry: In the center, a representative schematic of the entire chip that has reused an image from Fig. 4C (GEM NP gradient, top left) is depicted. The lateral images represent the zoom in at the cell level showing the immunocytochemistry Ki-67 staining after 5 days in culture [panels showing DAPI nuclei staining (blue), Ki-67 staining (green), F-actin staining (red), and merged image in colors].](https://figures.cochat.ai/paper-figures/67019409de02432a8df9bda6665dcdc4/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The platform was inspired by radial drug penetration (diffusion of small molecules from the outer boundaries into the central core of the tumor) into solid tumors, and it evaluated in real-time the interactions between colorectal cancer cells and endothelial cells that in fi ltrated the VEGF-infused tumor core [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To mimic the human colorectal TME and reconstitute functions of the microvascular tissue, a 3D micro fl uidic chipbased in vitro model was fabricated [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
In the citing paper
“The microvascularized colorectal-tumor-on-a-chip model was developed to investigate sprouting formation and drug screening applications.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
In the citing paper
“CRC cells, labeled in red, and HCoMECs, in yellow, respond to the incoming VEGF growth factor.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434 · cited 1×
“Angiogenesis is a complex morphogenetic process where endothelial cells from preexisting vessels invade the matrix as multicellular sprouts to form new vessels (29).”
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions
Chen, X.-G., & Park, H.-J. (2003) · Carbohydrate Polymers · doi:10.1016/s0144-8617(03)00051-1 · Cited by 784
Biomolecular gradients in cell culture systems
Keenan, T. M., & Folch, A. (2008) · Lab Chip · doi:10.1039/b711887b · Cited by 596
Filopodia in cell adhesion, 3D migration and cancer cell invasion
Jacquemet, G., Hamidi, H., & Ivaska, J. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.007 · Cited by 533
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Cited by
Items 101–200 of 229
Construction of cancer-on-a-chip for drug screening
Liu, Y., Yang, Q., Zhang, H., Han, S., Liu, N., Ren, H. J., Guo, H., & Xu, F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.006 · Cited by 22
Microfluidics for Angiogenesis Research
Costa, L., Reis, R. L., Silva‐Correia, J., & Oliveira, J. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_7 · Cited by 25
Self-citationEvolution of Metastasis Study Models toward Metastasis‐On‐A‐Chip: The Ultimate Model?
Ruiz‐Espigares, J., Nieto, D., Moroni, L., Jiménez, G., & Marchal, J. A. (2021) · Small · doi:10.1002/smll.202006009 · Cited by 23
Flores-Torres, S., Jiang, T., Kort-Mascort, J., Yang, Y. K., Peza-Chavez, O., Pal, S., Mainolfi, A., Pardo, L. A., Ferri, L. E., Bertos, N., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00998 · Cited by 25
Dhar, D., Ghosh, S., Mukherjee, S., Dhara, S., Chatterjee, J., & Das, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123999 · Cited by 33
Advancements in 3D In Vitro Models for Colorectal Cancer
Vitale, S., Calapà, F., Colonna, F., Luongo, F., Biffoni, M., Maria, R. D., & Fiori, M. E. (2024) · Advanced Science · doi:10.1002/advs.202405084 · Cited by 23
Zhou, L., Liu, L., Chang, M. A., Ma, C., Chen, W., & Chen, P. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115064 · Cited by 22
Nanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 24
Engineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
Lim, J., Fang, H., Bupphathong, S., Sung, P.-C., Yeh, C.-E., Huang, W. R., & Lin, C.-H. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01978 · Cited by 23
Micro/nanofluidic devices for drug delivery
Kashaninejad, N., Moradi, E., & Moghadas, H. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.018 · Cited by 23
“In one research, a biomimetic tumor-ona-chip platform was developed to emulate in vivo relevant colorectal tumor microenvironment and reconstruct functional microvasculature for precision nanomedicine delivery.(56) Colorectal cancer cells were seeded in matrigel-supported 3D structure, while endothelial cells were cul…”
MethodNieto, D., Jiménez, G., Moroni, L., López‐Ruiz, E., Gálvez‐Martín, P., & Marchal, J. A. (2022) · Medicinal Research Reviews · doi:10.1002/med.21914 · Cited by 20
“As the development of tumor‐on‐a‐chip advances, this novel technology acquires more and more complexity as demonstrated by the development of a complex 3D microfluidic chip model that emulates the colorectal TME with the ability to evaluate response to treatment in real‐time.(44) This chip was made of PDMS with a matr…”
MethodIntestine‐on‐a‐chip for intestinal disease study and pharmacological research
Zhang, D., & Qiao, L. (2022) · View · doi:10.1002/viw.20220037 · Cited by 20
Sood, A., Kumar, A., Gupta, V. K., Kim, C. M., & Han, S. S. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01080 · Cited by 22
Microphysiological systems for human aging research
Park, S., Laskow, T. C., Chen, J., Guha, P., Dawn, B., & Kim, D. (2024) · Aging Cell · doi:10.1111/acel.14070 · Cited by 23
“…3a; Kwak et al., 2014; Lanz et al., 2017), liver (Figure 3b; Lu et al., 2018), lung (Figure 3c; Hassell et al., 2017), colorectal (Figure 3d; Carvalho et al., 2019), brain (Fan et al., 2016; Liu et al., 2010; Xiao et al., 2019), and pancreatic cancer (Mao et al., 2020; Nishiguchi et al.,…”
BackgroundTiwary, P., Oswal, K., Varghese, R., Peri, R. V., & Gupta, P. K. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00109a · Cited by 19
New Endeavors of (Micro)Tissue Engineering: Cells Tissues Organs on-Chip and Communication Thereof
Ahmed, H. M. M., & Teixeira, L. M. (2021) · Cells Tissues Organs · doi:10.1159/000516356 · Cited by 19
“Various organs have been studied and key aspects were replicated on-chip, including lungs, liver, kidney, intestines, and tumor microenvironments [Benam et al., 2016; Shim et al., 2017; Carvalho et al., 2019; Sateesh et al., 2019; Langerak et al., 2020; Moradi et al., 2020].”
BackgroundSelf-citationBourn, M. D., Mohajerani, S. Z., Mavria, G., Ingram, N., Coletta, P. L., Evans, S. D., & Peyman, S. A. (2023) · Lab on a Chip · doi:10.1039/d2lc00963c · Cited by 20
3D Bioprinting for Tumor Metastasis Research
Lin, M., Tang, M., Duan, W., Xia, S., Liu, W., & Wang, Q. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00239 · Cited by 19
Efficacy of molecular and nano-therapies on brain tumor models in microfluidic devices
Martins, A. M., Brito, A., Barbato, M. G., Felici, A., Reis, R. L., Pires, R. A., Pashkuleva, I., & Decuzzi, P. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213227 · Cited by 17
Self-citationModels for barrier understanding in health and disease in lab-on-a-chips
Ponmozhi, J., Dhinakaran, S., Kocsis, D., Iván, K., & Erdő, F. (2023) · Tissue Barriers · doi:10.1080/21688370.2023.2221632 · Cited by 20
“They developed microfluidic platforms to investigate progression and drug sensitivity for colorectal, breast, and lung cancer cells 107,108 .”
BackgroundKim, S., Park, J., Ho, J., Kim, D., Lee, S., & Jeon, J. S. (2023) · Biofabrication · doi:10.1088/1758-5090/acef99 · Cited by 16
“Since previous microfluidic chips were generally semi-closed systems that required a destruction of chip to access the cells or a chemical cell lysis reagent for sample harvest, the confusion between different cell types was inevitable, making the process to be labor-extensive [31, 67, 68].”
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Kong, X., Xie, X., Wu, J., Wang, X., Zhang, W., Wang, S., Abbasova, D. V., Fang, Y., Jiang, H., Gao, J., et al. (2025) · 癌症:英文版 · doi:10.1002/cac2.70025 · Cited by 20
Microvessel-on-Chip Fabrication for the In Vitro Modeling of Nanomedicine Transport
Dávila, S., Cacheux, J., & Rodríguez, I. (2021) · ACS Omega · doi:10.1021/acsomega.1c00735 · Cited by 19
Simulating the Effect of Gut Microbiome on Cancer Cell Growth Using a Microfluidic Device
Mittal, E., Cupp, G., & Kang, Y. B. (2023) · Sensors · doi:10.3390/s23031265 · Cited by 18
“Most recently, there have been some attempts to show that cancer progression is associated with a microbiome while using a colorectal tumor chip [30,31] or during the testing drug efficacy [32,33].”
BackgroundNgo, H. T., Amartumur, S., Tran, V. T. A., Tran, M., Diep, Y. N., Cho, H., & Lee, L. P. (2023) · Biosensors · doi:10.3390/bios13020231 · Cited by 17
“Co-culturing HCT-116 colorectal cancer cells with human colonic microvascular endothelial cells on a circular chip revealed the invasion of endothelial cells toward HCT-116-secreting VEGF cells (Figure 3e, 2019) [97].”
BackgroundHarnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer
Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 16
“Platforms such as the Colorectal-tumor-on-a-chip have further enabled studies in nanoparticle distribution in precision nanomedicine (Carvalho et al., 2019).”
MethodVascular microphysiological systems (MPS): biologically relevant and potent models
Breuil, L., Kitada, A., Yadav, S., Zhou, H., Fujimoto, K., & Yokokawa, R. (2025) · Lab on a Chip · doi:10.1039/d5lc00014a · Cited by 19
Xu, N., Lin, H., Lin, J., Cheng, J., Wang, P., & Lin, L. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03892 · Cited by 15
Gallegos-Martínez, S., Buentello, D. C., Pérez-Álvarez, K. A., Lara-Mayorga, I. M., Aceves-Colin, A. E., Zhang, Y. S., Santiago, G. T., & Álvarez, M. M. (2024) · Biofabrication · doi:10.1088/1758-5090/ad5765 · Cited by 16
“ToCs can be used to conduct fundamental studies related to human cancerous tissues [8, 10] and to assess the efficacy or toxicity of anti-cancer drugs [12, 15–17].”
Building Blood Vessel Chips with Enhanced Physiological Relevance
Mu, X., Gerhard‐Herman, M. D., & Zhang, Y. S. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201778 · Cited by 16
Chuaychob, S., Lyu, R., Tanaka, M., Haginiwa, A., Kitada, A., Nakamura, T., & Yokokawa, R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312472121 · Cited by 15
Current and Future Trends of Silk Fibroin-Based Bioinks In 3D Printing
Oliveira, J. M. (2020) · Journal of 3D Printing in Medicine · doi:10.2217/3dp-2020-0005 · Cited by 14
Self-citationGut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
Pleguezuelos‐Manzano, C., Puschhof, J., & Clevers, H. C. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-095211 · Cited by 19
Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
Fernandes, S., Cassani, M., Pagliari, S., Filipenský, P., Cavalieri, F., & Forte, G. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200625151134 · Cited by 15
In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles
Abreu, T. R., Biscaia-Caleiras, M., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_12 · Cited by 18
Morán-Álvarez, A., González‐Menéndez, P., Mayo, J. C., & Sainz, R. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032717 · Cited by 15
Targeted Cancer Therapy‐on‐A‐Chip
Abed, H., Radha, R., Anjum, S., Paul, V., AlSawaftah, N., Pitt, W. G., Ashammakhi, N. A., & Husseini, G. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400833 · Cited by 13
Microfluidic systems in cancer research
Caballero, D., Luque‐González, M. A., Reis, R. L., & Kundu, S. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00015-0 · Cited by 13
Self-citationAl-Kaabneh, B., Frisch, B. J., & Aljitawi, O. S. (2022) · Cancers · doi:10.3390/cancers14215252 · Cited by 11
“As an example, one model has successfully regulated in vivo physiological processes via providing strict control of oxygen gradient, temperature, pH, and accurate spatiotemporal gradient in solid organ tumors [19].”
MethodSharkey, C., White, R., Finocchiaro, M. A., Thomas, J., Estevam, J., & Konry, T. (2024) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110222-102142 · Cited by 11
Separation of Microplastics from Blood Samples Using Traveling Surface Acoustic Waves
Mesquita, P., Lin, Y., Gong, L., & Schwartz, D. (2024) · Microplastics · doi:10.3390/microplastics3030028 · Cited by 14
Ramírez-González, G. A., Consumi-Tubito, C., Vargas-Méndez, E., & Centeno-Cerdas, C. (2025) · Polymers · doi:10.3390/polym17091263 · Cited by 14
“…to the endothelial invasion thanks to its vascular endothelial growth factor (VEGF), for which the cells seemed to follow a chemotactic signal toward the Matrigel source even though cell migration from the endothelium is not physically constrained in any direction by their system design [94].”
Song, S., Li, B., Carvalho, M. R., Wang, H., Mao, D., Wei, J., Chen, W., Weng, Z.-H., Chen, Y., Deng, C., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108276 · Cited by 11
Self-citationLab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases
Parimalam, S. S., Bǎdilescu, S., Sonenberg, N., Bhat, R., & Packirisamy, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246126 · Cited by 15
“Some of the above devices were already evaluated for drug screening [32,34,36,38,40], and a few studied the effect of NPs [35,41] and NMs [39].”
BackgroundEvaluation of Novel Dendrimer–Gold Complex Nanoparticles for Theranostic Application in Oncology
Milivojević, N. N., Carvalho, M. R., Caballero, D., Radisavljević, S., Radoičić, M. B., Živanović, M., Kundu, S. C., Reis, R. L., Filipović, N., & Oliveira, J. M. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0355 · Cited by 9
Self-citationTiwary, P., Oswal, K., Varghese, R., Anchan, H., & Gupta, P. K. (2025) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2025.105510 · Cited by 13
Barua, R., Das, D., & Biswas, N. (2025) · Biomicrofluidics · doi:10.1063/5.0268362 · Cited by 10
Sensors and Biosensors in Organs-on-a-Chip Platforms
López‐Muñoz, G. A., Mughal, S., & Ramón‐Azcón, J. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_3 · Cited by 10
Advancing Tumor Microenvironment Research by Combining Organs-on-Chips and Biosensors
Calejo, I., Heinrich, M. A., Zambito, G., Mezzanotte, L., Prakash, J., & Teixeira, L. M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_7 · Cited by 9
Self-citationCanadas, R. F., Liu, Z., Gasperini, L., Fernandes, D. C., Maia, F. R., Reis, R. L., Marques, A. P., Liu, C., & Oliveira, J. M. (2022) · Biofabrication · doi:10.1088/1758-5090/ac55a2 · Cited by 8
“Recently, even an interstitial-like, flow-induced, low, and constant shear stress showed to boost vascular network formation and maturation in 3D-engineered tissues [14, 15].”
Self-citationCellular Systems for Colorectal Stem Cancer Cell Research
Grigoreva, T. A., Kindt, D. N., Sagaidak, A. V., Novikova, D., & Tribulovich, V. G. (2025) · Cells · doi:10.3390/cells14030170 · Cited by 8
“In the case of colorectal cancer, cells obtained from the corresponding tumor lines or from patients are cultured in a microfluidic system [158–160].”
AI‐Driven Microphysiological Systems for Advancing Nanoparticle Therapeutics
Lee, Y., Min, J., Kim, S., & Ko, J. (2025) · Advanced Intelligent Systems · doi:10.1002/aisy.202500022 · Cited by 8
Advancements in Microfluidic Organ-on-a-chip for Oral Medicine
Fan, S., Ge, Y., Li, B., Liu, P., & Liu, X. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.100925 · Cited by 10
Engineering tumor spatial heterogeneity in vitro
Chen, C., Zhao, Z., Seah, D. H., Wu, K. Z., Mohanaselvi, S., & Fong, E. L. S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115757 · Cited by 13
Nanoparticles and Microfluidic Devices in Cancer Research
Maia, F. R., Reis, R. L., & Oliveira, J. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_10 · Cited by 9
Self-citationClinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
Wu, D., Huang, Q., Xu, Y., Cao, R., Yang, M., Xie, J., & Zhang, D. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118782 · Cited by 9
Dhar, D., Chatterjee, J., & Das, S. (2025) · RSC Advances · doi:10.1039/d5ra02192h · Cited by 7
The application of organoids in colorectal diseases
Liu, Y., Wang, D., Luan, Y., Tao, B., Li, Q., Feng, Q., Zhou, H., Mu, J., & Yu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412489 · Cited by 8
Research Progress in the Construction and Application of In Vitro Vascular Models
He, Z., Cheng, P., Ying, G., & Ou, Z. (2024) · Applied Sciences · doi:10.3390/app14156780 · Cited by 8
“Co-culture by measuring Co-culture also increased the expression of specific transporters, endothelial cell maturity, and model stability, allowing for distinguishing which new drug candidates are substrates for efflux transporters. transmembrane resistance.”
The progress and challenges in modeling colorectal cancer and the impact on novel drug discovery
Teixeira, N., Baião, A., Dias, S., & Sarmento, B. F. C. C. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2404238 · Cited by 9
“CRC-on-chip models represent a significant development in this field, combining microfluidic technology with 3D culture systems to create a more physiologically relevant environment [55].”
Measuring Nanoparticle Penetration Through Bio-Mimetic Gels
McCormick, S., Stillman, N., Hockley, M. J., Perriman, A. W., & Hauert, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s292131 · Cited by 8
Dynamic Culture Systems and 3D Interfaces Models for Cancer Drugs Testing
Fernandes, D. C., Canadas, R. F., Reis, R. L., & Oliveira, J. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_9 · Cited by 7
Self-citationTumor organoids on-a-chip and the role of AI in predictive oncology and personalized cancer medicine
Mirlohi, M. S., Hamdi, E., Karimi, M. H., Salami, S., Aref, A. R., Kohan, H. G., Ghayoor, A., Seyfoori, A., & Akbari, M. (2026) · Biofabrication · doi:10.1088/1758-5090/ae3644 · Cited by 7
“A microfluidics-based hydrogel device recreated the intricate 3D microenvironment that can be used as a drug screening platform and for genetic analysis as a treatment for individual patients [118].”
Recapitulating Solid Stress on Tumor on a Chip for Nanomedicine Diffusive Transport Prediction
Martín–Asensio, A., Dávila, S., Cacheux, J., Lindstaedt, A., Dziadosz, A., Witt, D., Calero, M., Balaž, I., & Rodríguez, I. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200164 · Cited by 6
Organoids for Cancer Research: Advances and Challenges
Xin, M., Li, Q., Wang, D., & Wang, Z. (2024) · Advanced Biology · doi:10.1002/adbi.202400056 · Cited by 6
Carvalho, M. R., Ribeiro, V., Caballero, D., Kundu, S., Reis, R., & Oliveira, J. M. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad8829 · Cited by 11
“In this study, we took advantage of our experience with the use of SF in tissue engineering, micro-fluidics modelling and CRC [14, 23] to design a unique human colorectal tumor model built on the novel soft microfluidic platform.”
Self-citationCarton, F., & Malatesta, M. (2022) · European Journal of Histochemistry · doi:10.4081/ejh.2022.3603 · Cited by 6
Caballero, D., Kundu, B., Abreu, C. M., Amorim, S., Fernandes, D. C., Pires, R. A., Oliveira, J. M., Correlo, V. M., Reis, R. L., & Kundu, S. C. (2022) · In vitro models · doi:10.1007/s44164-022-00014-z · Cited by 7
“Their performance was validated on-chip, displaying a remarkable ability to target the cancer cells and intracellularly deliver the therapeutic cargo avoiding undesired toxicities [12].”
BackgroundSelf-citationTrends in biomaterials for three-dimensional cancer modeling
Caballero, D., Reis, R. L., & Kundu, S. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00001-0 · Cited by 6
Self-citationThe prospects for bioprinting tumor models: recent advances in their applications
Zhang, C., Qiu, X., Dai, Y., Kong, W., Liu, Y., Niu, H., Wang, C., Mi, X., Wang, H., Ya, R., et al. (2023) · Bio-Design and Manufacturing · doi:10.1007/s42242-023-00247-1 · Cited by 6
“Carvalho et al. [107] developed a sophisticated in vitro model using a 3D microfluidic chip to mimic the microenvironment of human colorectal tumors.”
The translational roadmap of the gut models, focusing on gut-on-chip
Malaguarnera, G., Graute, M., & Homs-Corbera, A. (2021) · Open Research Europe · doi:10.12688/openreseurope.13709.1 · Cited by 10
Hashemzadeh, H., Eshkiki, Z. S., Kelkawi, A. H. A., Rafati, N., Gaaib, J. N., Agah, S., Tabaeian, S. P., Beigi, S. N., Namazi, A., Akbari, A., et al. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217556 · Cited by 4
Global Literature Analysis of Tumor Organoid and Tumor-on-Chip Research
Shoji, J., Davis, R. P., Mummery, C. L., & Krauss, S. J. K. (2025) · Cancers · doi:10.3390/cancers17010108 · Cited by 5
Kim, A.-I., Oh, J. H., & Cho, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27148 · Cited by 4
“Furthermore, Ki-67, a universally accepted marker, was employed to evaluate cellular proliferation [14].”
Ibrahim, R. S., El‐Wadood, H. M. A., El‐Zahry, M. R., & Hosny, N. M. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113137 · Cited by 4
Bioengineering mini-colons for ex vivo colorectal cancer research
Lorenzo‐Martín, L. F., Hübscher, T., Langer, J., Nikolaev, M., & Lütolf, M. P. (2025) · Nature Protocols · doi:10.1038/s41596-025-01292-z · Cited by 6
Advancements in Organ‐on‐a‐Chip Systems: Materials, Characterization, and Applications
Gunasekaran, B. M., Srinivasan, S., Ezhilan, M., Rajagopal, V., & Nesakumar, N. (2024) · ChemistrySelect · doi:10.1002/slct.202403611 · Cited by 5
Dendrimers in tissue engineering
Oliveira, I. M., Carvalho, M. R., Reis, R. L., & Oliveira, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821250-9.00008-1 · Cited by 3
Self-citationZarei, F., Besanjideh, M., & Shamloo, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106134 · Cited by 3
Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response
Jeevanandan, S. P., Reidy, E., Clegg, J., Curvello, R., Ryan, A. E., & Loessner, D. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02681-y · Cited by 2
“To test the effect of drug-loaded nanoparticles and vascular delivery, a colorectal cancer-on-a-chip device was developed [137].”
Kang, S. J., Yoon, M. S., Lee, J. M., Jo, M. J., Jin, C. E., & Shin, D. H. (2026) · Advanced Science · doi:10.1002/advs.77137 · Cited by 2
“Although quantitative evaluation of nanoparticle transport under dynamic exposure conditions remains challenging, the PE/m-platform provides a controlled approach for assessing size-selective transport across a defined permeability barrier [ 44, 50 ].”
Liu, Z., Yu, Z., Dong, J., Yang, D., Li, J., He, Z., Zhou, J., & Huang, L. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202200758 · Cited by 2
Vascularized platforms for investigating cell communication via extracellular vesicles
Kim, J., Ro, J., & Cho, Y. (2024) · Biomicrofluidics · doi:10.1063/5.0220840 · Cited by 2
Nix, C., & Fillet, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-444-59432-7.00017-0 · Cited by 2
Li, G., Liu, Y., Yao, J., Song, K., Wang, G., Zhou, L., Chen, G., & Liu, L. (2021) · Chinese Physics B · doi:10.1088/1674-1056/ac381c · Cited by 2
A Microfludic Platform as An In Vitro Model for Biomedical Experimentation - A Cell Migration Study
Milivojević, N. N., Caballero, D., Carvalho, M. R., Kokanović, M., Živanović, M., Filipović, N., Reis, R. L., & Oliveira, J. M. (2021) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe52308.2021.9635498 · Cited by 2
Self-citationOrgan-on-chip for assessing environmental toxicants
Polaka, S., Pulugu, P., Tekade, M., Sharma, M. C., & Tekade, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98367-9.00018-4 · Cited by 2
Caspases activity assay procedures
Satapathy, S., Kumar, S., Nigam, V., Kurmi, B. D., Vaidya, A., Ved, A., & Patel, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15644-1.00009-2 · Cited by 2
Avatar: The Way of Complex In Vitro Models in Cancer Nanomedicine
Mahadik, K., Dhurde, T., Sivakumar, M. B., & Rao, N. M. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500368 · Cited by 1
Hassani, I., Anbiah, B., Tian, Y., Ahmed, B., Pol, W. V. D., Lefkowitz, E. J., Kuhlers, P. C., Habbit, N. L., Heslin, M. J., Greene, M. W., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.02.051 · Cited by 2
Zhang, X., Zhu, X., Chen, Y., & Lu, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1827951 · Cited by 2
“Assessments of drug delivery and penetration have also been realized within comparable colorectal cancer organ-on-a-chip platforms (52, 53).”
Tumor organoids as a revolutionary platform for advancing cancer nanomedicine
Wu, C., Chen, J., Zhang, C. M., Ji, J., Tan, Y., Liu, Z., Wu, Q., Zheng, X., Luo, K., & Xiao, K. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02702-w · Cited by 2
“To date, a diverse array of human tumor organoid chips has been developed, encompassing models of lung [99], brain [100], liver [101], colorectal [102], breast [103], and pancreatic [104] cancers.”
The Role of Organ-on-a-Chip Technology in Advancing Precision Medicine
Caballero, D., Reis, R. L., & Kundu, S. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00050-2 · Cited by 1
Self-citationMicrofluidic platforms: applications and challenges
Vijay, A., Nechikat, G., & John, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00028-0 · Cited by 1
El‐Tayeb, M. A. (2025) · Current Microbiology · doi:10.1007/s00284-025-04306-x · Cited by 1
“Models of the small intestine [123] and large intestine [124] on microfluidic chips have proven effective in examining various physiological and pathological processes, including metabolism, cancer, host-microbiome interactions, and infections.”
Development of Microfluidic Lab-on-Chip System for Cultivation of Cells and Tissues
Milivojević, N. N., Nikolić, D. D., Šeklić, D., Pešić, Ž. J., Živanović, M., & Filipović, N. (2021) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-73909-6_81 · Cited by 1
Desarrollo de métodos integrados para la determinación de biomarcadores genéticos
Martorell, S. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/176006
Micro/Nano Devices for Blood Analysis, Volume II
Lima, R. A., Minas, G. M. H., & Catarino, S. O. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3228-8
Microengineered arterial wall-on-a-chip to model atherosclerosis
Su, C. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155569
Metadata
- Authors
- Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P.
- Affiliations
- 3B's Research Group (PT)
- Maastricht University (NL)
- Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.
- Corresponding author
- Oliveira, J. M.
- ORCID
- Venue
- Science Advances
- Published
- 2019-05-03
- Volume
- 5
- Issue
- 5
- Pages
- eaaw1317-eaaw1317
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6531003
- OpenAlex
- W2946416309
- Cited by
- 230
- References
- 49
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 44 · 2023: 40 · 2022: 32 · 2021: 38 · 2020: 29 · 2019: 3
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- EMBO (Short-Term Fellowship 7232)
- FCT (NORTE-01-0145-FEDER-000023, IF/01285/2015)
- Norte Portugal Regional Operational Programme (NORTE-08-5369-FSE- 000044)
- IET A F Harvey Engineering (IET A F Harvey Engineering Research Prize 2018 (ENG ThE CANCER))
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- colorectal cancer, tumor-on-a-chip, 3D tumor models, precision nanomedicine, precision oncology, cancer nanomedicine
- MeSH terms
- Cell Survival, Humans, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Coculture Techniques, Ki-67 Antigen, Matrix Metalloproteinase 1, Imaging, Three-Dimensional, Biomimetics, Microfluidics, HCT116 Cells, Cell Line, Tumor, Dendrimers, Nanomedicine, Caspase 3, Nanoparticles, Lab-On-A-Chip Devices, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.